Nora Henrikson, PhD, MPH
"I believe that our members are the key to helping us know how to deliver the best care possible."
Nora Henrikson, PhD, MPH
Associate Investigator, Kaiser Permanente Washington Health Research Institute
Associate Professor, Kaiser Permanente Bernard J. Tyson School of Medicine, Department of Health Systems Science
Affiliate Associate Professor, University of Washington School of Public Health, Department of Health Systems and Population Health, and Institute for Public Health Genetics
Biography
Nora Henrikson (she/her) is an associate investigator at Kaiser Permanente Washington Health Research Institute. She leads a research portfolio focused on interventions to improve cancer care delivery, health equity, and patient outcomes.
Her current research explores methods for improving risk notification and cascading genetic testing for family members of people with hereditary cancers as well as interventions to mitigate cancer-related financial hardship. Dr. Henrikson also leads systematic evidence reviews on cancer screening and behavioral counseling with the Kaiser Permanente Evidence-based Practice Center.
Dr. Henrikson holds affiliate faculty appointments at the University of Washington School of Public Health in the Department of Health Systems and Population Health, and the Institute for Public Health Genetics. She is also an associate professor at the Bernard J. Tyson Kaiser Permanente School of Medicine.
She has a PhD from the University of Washington School of Public Health’s Institute for Public Health Genetics, an MPH from the University of North Carolina at Chapel Hill, and a BA (sociology) from Lehigh University.
RESEARCH INTERESTS AND EXPERIENCE
-
Cancer
Genetic testing for cancer risk, cancer-related financial hardship
-
Social Determinants of Health
Financial hardship, health equity
-
Health Services & Economics
Quantitative, qualitative, and mixed methods; intervention design; implementation science
-
Preventive Medicine
-
Evidence-Based Practice
Systematic review and evidence synthesis; epidemiology
-
Public Health Genetics
Social, ethical, and policy implications of genomics and precision health
Recent publications
Parchman ML, Henrikson NB, Blasi PR, Buist DS, Penfold R, Austin B, Ganos EH. Taking action on overuse: creating the culture for change. Healthc (Amst). 2016 Nov 10. pii: S2213-0764(16)30167-1. doi: 10.1016/j.hjdsi.2016.10.005. [Epub ahead of print]. PubMed
Henrikson NB, Lau RW, Tuzzio L, Christianson M, Phan TH, Chen E. Treatment prices at the point of care in a clinical oncology service: pilot project. J Oncol Pract. 2016 Oct;12(10):e957-e963. PubMed
Lozano P, Henrikson NB, Morrison CC, Dunn J, Nguyen M, Blasi PR, Whitlock EP. Lipid screening in childhood and adolescence for detection of multifactorial dyslipidemia: evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2016 Aug 9;316(6):634-44. doi: 10.1001/jama.2016.6423. PubMed
Lozano P, Henrikson NB, Dunn J, Morrison CC, Nguyen M, Blasi PR, Anderson ML, Whitlock EP. Lipid screening in childhood and adolescence for detection of familial hypercholesterolemia: evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2016 Aug 9;316(6):645-55. doi: 10.1001/jama.2016.6176. PubMed
Wernli KJ, Henrikson NB, Morrison CC, Nguyen M, Pocobelli G, Blasi PR. Screening for skin cancer in adults: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA.2016;316(4):436-447. doi:10.1001/jama.2016.5415. PubMed
Lowery JT, Ahnen DJ, Schroy PC 3rd, Hampel H, Baxter N, Boland CR, Burt RW, Butterly L, Doerr M, Doroshenk M, Feero WG, Henrikson N, Ladabaum U, Lieberman D, McFarland EG, Peterson SK, Raymond M, Samadder NJ, Syngal S, Weber TK, Zauber AG, Smith R. Understanding the contribution of family history to colorectal cancer risk and its clinical implications: a state-of-the-science review. Cancer. 2016 Jun 3. doi: 10.1002/cncr.30080. [Epub ahead of print]. PubMed
Lozano P, Henrikson NB, Dunn J, Morrison CC, Nguyen M, Whitlock EP. Lipid screening in childhood for detection of multifactorial dyslipidemia: a systematic evidence review for the U.S. Preventive Services Task Force. Evidence Synthesis No. 140. AHRQ Publication No. 14-05204-EF-1. Rockville, MD: Agency for Healthcare Research and Quality;2015. PubMed
Lozano P, Henrikson NB, Dunn J, Morrison CC, Nguyen M, Whitlock EP. Lipid screening in childhood and adolescence for detection of familial hypercholesterolemia: a systematic evidence review for the U.S. Preventive Services Task Force. Evidence Synthesis No. 141. AHRQ Publication No. 14-05204-EF-2. Rockville, MD: Agency for Healthcare Research and Quality; 2015. PubMed
Henrikson NB, Shankaran V. Improving price transparency in cancer care. J Oncol Pract. 2016;12(1):44-7. doi: 10.1200/JOP.2015.006171. PubMed
Blasi PR, King D, Henrikson NB. HPV vaccine public awareness campaigns: an environmental scan. Health Promot Pract. 2015 Nov;16(6):897-905. doi: 10.1177/1524839915596133. Epub 2015 Jul 28. PubMed
Healthy findings blog
How do you make sense of a mountain of evidence?
KPWHRI researchers answer questions about systematic reviews and their impact on health care guidelines.
HCSRN conference
Researchers present, connect at annual conference
The HCSRN conference is a venue for collaborative work to improve health and health care.
profile
Why does Nora Henrikson study patients’ cost of treatment?
Dr. Henrikson’s Annals of Internal Medicine study describes 3 kinds of cost concerns that can affect cancer care.
video
Discussing patients’ concerns about cost of care
Nora Henrikson discusses her latest research published in the Annals of Internal Medicine in May 2019. (Vimeo, 3:50)
Land Acknowledgment
Our Seattle offices sit on the occupied land of the Duwamish and by the shared waters of the Coast Salish people, who have been here thousands of years and remain. Learn about practicing land acknowledgment.